home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

U.S. Federal Register - Notice of intent to prepare an environmental impact statement for the proposed rule, standards for growing, harvesting, packing, and holding of produce for human consumption


Washington, DC, USA
August 19, 2013

[Federal Register Volume 78, Number 160 (Monday, August 19, 2013)]
[Proposed Rules]
[Pages 50358-50359]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-20087]

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 112
[Docket No. FDA-2011-N-0921]
RIN 0910-AG35

Notice of Intent To Prepare an Environmental Impact Statement for the Proposed Rule, Standards for Growing, Harvesting, Packing, and Holding of Produce for Human Consumption

AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of Intent.

SUMMARY: Under the National Environmental Policy Act of 1969 (NEPA), as implemented by the Council on Environmental Quality (CEQ) regulations, the Food and Drug Administration (FDA) announces its intent to prepare an Environmental Impact Statement (EIS) to evaluate the potential environmental effects of the proposed rule, Standards for Growing, Harvesting, Packing, and Holding of Produce for Human Consumption. By this notice, FDA is announcing the beginning of the scoping process to solicit public comments and identify issues to be analyzed in an EIS. Information on the proposed rule may be accessed using the docket
number found in brackets in the heading of this document.

DATES: This notice initiates the public scoping process for the EIS which will close on November 15, 2013. The Agency will consider comments in response to this notice to determine the need for any public scoping meetings prior to the preparation of the Draft EIS. In
order to be considered during the preparation of the Draft EIS, all comments must be received prior to the close of the public scoping period. All relevant and substantive comments submitted to Docket No. FDA-2011-N-0921 in response to the proposed rule will be considered as part of the scoping process. FDA will provide additional opportunities for public participation upon publication of the Draft EIS.

Full notice



More news from: U.S. Food and Drug Administration (FDA)


Website: http://www.fda.gov

Published: August 19, 2013

The news item on this page is copyright by the organization where it originated
Fair use notice

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

  Archive of the news section

 


Copyright @ 1992-2024 SeedQuest - All rights reserved